Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02820857 |
|---|---|
| Brief Title: | Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer (BEVANEC) |
| First Submitted : | June 29, 2016 |
| First Submitted that Met QC Criteria : | June 29, 2016 |
| First Posted : | July 1, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 7, 2024 |
| Last Update Posted : | May 8, 2024 |